Nelson Leung

2002–2025 年に発表

283
論文数
31,866
被引用数
96
h 指数
260
i10 指数

被引用数

Nelson Leung の年別被引用数2003 年: 被引用 1 件2004 年: 被引用 5 件2005 年: 被引用 4 件2006 年: 被引用 14 件2007 年: 被引用 15 件2008 年: 被引用 31 件2009 年: 被引用 30 件2010 年: 被引用 34 件2011 年: 被引用 75 件2012 年: 被引用 141 件2013 年: 被引用 158 件2014 年: 被引用 140 件2015 年: 被引用 174 件2016 年: 被引用 225 件2017 年: 被引用 175 件2018 年: 被引用 266 件2019 年: 被引用 796 件2020 年: 被引用 1,057 件2021 年: 被引用 956 件2022 年: 被引用 797 件2023 年: 被引用 791 件2024 年: 被引用 1,499 件2025 年: 被引用 697 件2026 年: 被引用 7 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,401 件、この内訳の 25.1%中国: 引用元論文 664 件、この内訳の 7%イタリア: 引用元論文 660 件、この内訳の 6.9%イギリス: 引用元論文 610 件、この内訳の 6.4%ドイツ: 引用元論文 585 件、この内訳の 6.1%フランス: 引用元論文 498 件、この内訳の 5.2%スペイン: 引用元論文 392 件、この内訳の 4.1%カナダ: 引用元論文 317 件、この内訳の 3.3%オランダ: 引用元論文 301 件、この内訳の 3.2%日本: 引用元論文 228 件、この内訳の 2.4%オーストラリア: 引用元論文 222 件、この内訳の 2.3%ギリシャ: 引用元論文 218 件、この内訳の 2.3%
0%25.1%その他 25.7%

分野

  • Medicine67.6%
  • Biochemistry, Genetics and Molecular Biology23.1%
  • Immunology and Microbiology4.1%
  • Computer Science2.1%
  • Materials Science0.8%
  • Chemistry0.5%
  • その他1.8%

トピック

  • Multiple Myeloma Research and Treatments9%
  • Amyloidosis: Diagnosis, Treatment, Outcomes6.9%
  • Renal Diseases and Glomerulopathies5.3%
  • Protein Degradation and Inhibitors3.6%
  • Lymphoma Diagnosis and Treatment3.5%
  • Chronic Lymphocytic Leukemia Research2.7%
  • その他69%

共著者

全論文

検索で開く
  1. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andreas Hochhaus, Patty M. Jansen, Kennosuke Karube, Werner Kempf, Joseph D. Khoury, Hiroshi Kimura, Wolfgang Hiddemann, Alexandra E. Kovach, Shaji Kumar, Alexander J. Lazar, Stefano Lazzi, Lorenzo Leoncini, Nelson Leung, Vasiliki Leventaki, Xiao‐Qiu Li, Megan S. Lim, Weiping Liu, Abner Louissaint, Andrea N. Marcogliese, L. Jeffrey Medeiros, Michael Michal, Roberto N. Miranda, Christina Mitteldorf, Santiago Montes‐Moreno, William G. Morice, Valentina Nardi, Kikkeri N. Naresh, Yasodha Natkunam, Siok‐Bian Ng, Ilske Oschlies, German Ott, Marie Parrens, Melissa Pulitzer, S. Vincent Rajkumar, Andy C. Rawstron, Karen L. Rech, Andreas Rosenwald, Jonathan Said, Clémentine Sarkozy, Shahin Sayed, Caner Saygin, Anna Schuh, William A. Sewell, Reiner Siebert, Aliyah R. Sohani, Reuben Tooze, Alexandra Traverse‐Glehen, Francisco Vega, B. Vergier, Ashutosh Wechalekar, Brent L. Wood, Luc Xerri, Wenbin Xiao - Leukemia 2022 被引用: 3,736

  2. Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jay Radhakrishnan, Heather N. Reich, Samir V. Parikh, Debbie S. Gipson, Dominic K. Lee, Bruno R. da Costa, Peter Jüni, Daniel Cattran - New England Journal of Medicine 2019 被引用: 600

  3. Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements

    著者: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2012 被引用: 1,124

  4. Cisplatin nephrotoxicity: a review of the literature

    著者: , - Journal of Nephrology 2017 被引用: 629

  5. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients

    著者: , , , , , , , , , , , , , , , - Leukemia 2013 被引用: 1,396

  6. A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction

    著者: , , , , , , , , , , , , , , , , , - Journal of the American Society of Nephrology 2016 被引用: 288

  7. Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working Group

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jesús F. San Miguel, Kenneth C. Anderson, Edward A. Stadtmauer, Rao Prabhala, Phillip McCarthy, Nikhil C. Munshi - The Lancet Haematology 2022 被引用: 191

  8. Systemic amyloidosis from A (AA) to T (ATTR): a review

    著者: , , , , , , , , , , , - Journal of Internal Medicine 2020 被引用: 320

  9. Glomerulonephritis: immunopathogenesis and immunotherapy

    著者: , , , - Nature reviews. Immunology 2023 被引用: 164

  10. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ashutosh Wechalekar, Brendan M. Weiss, Samih H. Nasr - Nature Reviews Nephrology 2018 被引用: 534

  11. Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Blood Cancer Journal 2018 被引用: 289

  12. Monoclonal Gammopathy of Renal Significance

    著者: , , - New England Journal of Medicine 2021 被引用: 191

  13. Narsoplimab, a Mannan-Binding Lectin-Associated Serine Protease-2 Inhibitor, for the Treatment of Adult Hematopoietic Stem-Cell Transplantation–Associated Thrombotic Microangiopathy

    著者: , , , , , , , , , , , , - Journal of Clinical Oncology 2022 被引用: 98

  14. Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2023 被引用: 121

  15. Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myeloma

    著者: , , , , , , , , , , , , , , , , , , , , , , - American Journal of Hematology 2023 被引用: 53

  16. Biomarkers, Clinical Features, and Rechallenge for Immune Checkpoint Inhibitor Renal Immune-Related Adverse Events

    著者: , , , , , , , , , - Kidney International Reports 2021 被引用: 108

  17. A simple additive staging system for newly diagnosed multiple myeloma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Blood Cancer Journal 2022 被引用: 95

  18. Hematopoietic Stem Cell Transplant-Membranous Nephropathy Is Associated with Protocadherin FAT1

    著者: , , , , , , , , , , , , - Journal of the American Society of Nephrology 2022 被引用: 108

  19. Mortality trends in multiple myeloma after the introduction of novel therapies in the United States

    著者: , , , , , , , , , , , , , , , , , , , , , , - Leukemia 2021 被引用: 102

  20. Mayo Clinic/Renal Pathology Society Consensus Report on Pathologic Classification, Diagnosis, and Reporting of GN

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , An S. De Vriese, Jai Radhakrishnan, Lorraine C. Racusen, Pierre Ronco, Fernando C. Fervenza - Journal of the American Society of Nephrology 2015 被引用: 309

  21. Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications

    著者: , , , , , , - Blood 2018 被引用: 292

  22. Simulation-Based Approaches for Determining Membrane Permeability of Small Compounds

    著者: , , , , , , , , , , , - Journal of Chemical Information and Modeling, J. Chem. Inf. Model. 2016 被引用: 228

  23. International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2016 被引用: 419

  24. Biopsy-Proven Acute Interstitial Nephritis, 1993-2011: A Case Series

    著者: , , , , , , - American Journal of Kidney Diseases 2014 被引用: 344